Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Enerzair Breezhaler, indacaterol,glycopyrronium bromide,mometasone, Asthma, Date of authorisation: 03/07/2020, Revision: 5, Status: Authorised
TO: